26 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
of Sale Prospectus or the Prospectus.
(ii) Anti-Corruption and Anti-Bribery Laws. Neither the Company nor any of its subsidiaries nor any director … , as amended (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, authorized, requested
424B3
TRML
Tourmaline Bio Inc
15 Sep 23
Prospectus supplement
6:31am
serious consequences for violations.
Talaris is subject to anti-corruption laws, including the U.S. domestic bribery statute contained in 18 U.S.C … -bribery provisions or provisions of anti-corruption or anti-bribery laws in other countries.
Any of these factors could harm Tourmaline’s ongoing
S-4/A
u05u10nmq9oj7w
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
EX-10.4
tmd24p5x
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
0elqusar7 qf56van8
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
6sxlcf7i ffbd
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
y42l0bynz3zqoky12y0
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
10-K
l4919d7ukk0 ds
17 Mar 22
Annual report
4:31pm